News

AddToAny

Google+ Facebook Twitter Twitter

Genetic atlas of proteins

An international team of researchers led by scientists at the University of Cambridge has created the first detailed genetic map of human proteins.

This will be used to enhance our understanding of a wide range of diseases and aid development of new drugs.

The study characterised the genetic underpinnings of the human plasma “proteome” and identifies nearly 2,000 genetic associations with almost 1,500 proteins.

Previously, there was only a small fraction of this knowledge, as researchers could measure only a few proteins simultaneously in a robust manner. The researchers used a new technology to measure 3,600 proteins in the blood of 3,300 people.

They then analysed the DNA of these individuals to see which regions of their genomes were associated with protein levels, yielding a four-fold increase on previous knowledge.

Adam Butterworth, one of the authors, said: “Compared to genes, proteins have been relatively understudied in human blood, even though they are the ‘effectors’ of human biology, are disrupted in many diseases, and are the targets of most medicines. Novel technologies now allow us to start addressing this gap in our knowledge.”

One of the uses for this genetic map is to identify particular biological pathways that cause disease, exemplified in the paper by pinpointing specific pathways that lead to Crohn’s disease and eczema.

The researchers are making all of their results openly available for use.

go.nature.com/2JDzH2i

Related Articles

Transfusion: training hub

Jill Caulfield, Transfusion 2024 Education Development Lead at NHS Blood and Transplant, introduces a “one-stop shop” of training resources.

VR-headset - CREDIT -getty

Improving transfusion with training

Ruth Evans and Laura Eastwood from NHS Blood and Transplant discuss virtual reality training for blood transfusion testing.

red blood cells CREDIT-iStock-1227353965

Casestudy acquired protein s deficiency

Healthcare Science Section Lead in Haematology and Haemostasis Michelle Bolam presents a case study in which a two-year-old presented with an unprovoked extensive deep vein thrombosis.

paper cuts - CREDIT - Richard-Gleed

DNA: Cutting the future of genome editing

The latest CRISPR-Cas technology has been used to eliminate all traces of HIV from infected cells in the lab. Here we look at how gene editing could revolutionise clinical treatments and ask what the limitations are for its future use.

Top